Repharm parent company ‘AB City’ conditionally allowed to buy ‘Olainfarm’* On June 14, the Competition Council (CC) made a decision to allow JSC “AB City” to acquire a sole decisive influence over JSC “Olainfarm”. At the same time, in order to prevent possible risks to competition and negative consequences of the merger in the retail market of pharmaceutical products, the merger is permitted by binding regulations providing for the disposal of shares in SIA “LATVIJAS APTIEKA” to a third party unrelated to AS “AB CITY” and related parties. JSC “AB CITY” is the parent company of JSC “Repharm”, and the activities of its group of companies is engaged in the manufacture and sale of pharmaceutical products and medicines, the manufacture and sale of cosmetics, the manufacture and sale of dietary
Share on
|
|
The Latvian Competition Authority allows the acquisition of a pharmaceutical by a rival, conditional on the spinning off of some operations (AB City / Olainfarm)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.
